F/m Emerald Life Sciences Innovation ETF Rating $24.43 +0.21 (+0.87%) Closing price 09:28 AM EasternExtended Trading$24.43 0.00 (0.00%) As of 09:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsTrendsBuy This Stock F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.99Holdings in LFSC have an aggregate rating of Moderate Buy based on 269 analyst ratings issued in the past year covering 25 companies (92.8% of the portfolio).LFSC Aggregate Price Target$24.43High Prediction$24.43Average Prediction$24.43Low Prediction$24.43Holdings in LFSC have an aggregate price target of $24.43 and a range of $24.43 to $24.43 covering 25 companies (92.8% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 LFSC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.25%BBIOBridgeBio Pharma$47.46+0.2%4.7635 of 5 stars3.00$61.18 28.9%17Upcoming Earnings6.22%LIVNLivaNova$41.77+1.5%3.1067 of 5 stars3.00$59.29 42.0%8Positive NewsUpcoming Earnings6.02%TMDXTransMedics Group$128.82+6.9%2.4619 of 5 stars2.78$123.00 -4.5%9Earnings ReportAnalyst Forecast6.02%SLNOSoleno Therapeutics$85.45-0.6%4.2707 of 5 stars3.09$108.70 27.2%11Positive NewsUpcoming Earnings5.79%RDNTRadNet$55.03+0.6%4.0489 of 5 stars3.50$69.60 26.5%6Positive NewsUpcoming Earnings5.13%TVTXTravere Therapeutics$15.59-0.3%1.8953 of 5 stars2.87$32.14 106.2%15Upcoming EarningsShort Interest ↑4.87%KALVKalVista Pharmaceuticals$13.14-0.5%3.8078 of 5 stars3.11$26.29 100.1%94.77%MMSIMerit Medical Systems$84.50-0.3%4.5631 of 5 stars2.89$107.00 26.6%9Earnings Report4.44%COLLCollegium Pharmaceutical$30.24+0.5%3.9883 of 5 stars2.75$43.75 44.7%4Upcoming Earnings4.16%RAREUltragenyx Pharmaceutical$27.93-1.8%4.4857 of 5 stars2.92$83.08 197.5%134.04%INSMInsmed$108.56-0.1%3.6948 of 5 stars3.00$109.20 0.6%17Positive NewsUpcoming Earnings3.87%ETNB89BIO$9.22+0.7%2.3425 of 5 stars3.00$26.43 186.6%83.60%ATECAlphatec$14.17+2.9%4.2097 of 5 stars3.00$18.33 29.4%6News CoverageEarnings ReportAnalyst ForecastGap Up3.55%GHGuardant Health$41.85+1.0%4.4518 of 5 stars3.05$54.95 31.3%20Earnings Report3.11%MDGLMadrigal Pharmaceuticals$307.51+1.8%4.2795 of 5 stars2.89$420.63 36.8%9Positive NewsUpcoming Earnings3.02%WVEWAVE Life Sciences$8.52-1.3%4.6918 of 5 stars2.93$20.27 138.0%15Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.67%CORTCorcept Therapeutics$67.25-2.5%4.6933 of 5 stars3.00$134.50 100.0%5Earnings ReportAnalyst ForecastAnalyst RevisionGap Down2.56%MIRMMirum Pharmaceuticals$50.96-2.0%3.9601 of 5 stars3.13$65.50 28.5%8Upcoming Earnings2.27%ITGRInteger$107.15+0.6%3.3496 of 5 stars3.00$140.25 30.9%92.10%COGTCogent Biosciences$11.36-0.4%3.0491 of 5 stars2.82$18.70 64.7%11Upcoming Earnings2.07%AXSMAxsome Therapeutics$98.52-4.4%4.8012 of 5 stars3.06$172.33 74.9%16News CoverageEarnings Report1.82%ACADACADIA Pharmaceuticals$23.520.0%3.8788 of 5 stars2.71$28.13 19.6%17Upcoming Earnings1.62%AKROAkero Therapeutics$48.52+0.3%3.975 of 5 stars3.00$81.57 68.1%7Positive NewsUpcoming Earnings1.47%SYRESpyre Therapeutics$16.04-1.4%2.2398 of 5 stars3.29$53.40 233.0%7Upcoming EarningsGap Down1.38%GMEDGlobus Medical$52.83+0.4%4.8574 of 5 stars2.62$90.09 70.5%13Upcoming Earnings This page (NASDAQ:LFSC) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
